Early-stage drug candidate diminishes deficits in Parkinson's disease
University of Utah Health scientists have identified a molecule that slows cells' production of alpha-synuclein, a protein that forms toxic aggregates in the brains of people with Parkinson's disease. Its discovery points ...
Sep 21, 2021
0
67